Feedback / Questions
Bimzelx (bimekizumab-bkzx) - UCB
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
https://www.ucb.com/newsroom/press-releases/article/bimzelxrbimekizumab-demonstrates-superior-efficacy-over-skyrizir-risankizumab-in-psoriatic-arthritis-be-bold-week-16-data
May 19, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next